ID

25152

Descrição

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Standard of care medications

Palavras-chave

Versões (3)
  1. 27/08/2017 27/08/2017 -
  2. 23/10/2017 23/10/2017 -
  3. 12/12/2017 12/12/2017 -
Titular dos direitos

GlaxoSmithKline

Transferido a

27 de agosto de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0
Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Voltar para os comentários do modelo
Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

Inglês

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários  
Standard of care medications
Descrição

Standard of care medications

1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
Descrição

STATIN therapy prior to randomisation

Tipo de dados

boolean

2. Was the subject taking STATIN therapy at the time of randomisation?
Descrição

STATIN therapy at randomisation

Tipo de dados

boolean

If no, indicate reason
Descrição

no STATIN therapy at randomisation reason

Tipo de dados

text

If other reason, specify:
Descrição

no STATIN therapy at randomisation other reason

Tipo de dados

text

3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
Descrição

ASPIRIN therapy prior to randomisation

Tipo de dados

boolean

4. Was the subject taking ASPIRIN at the time of randomisation?
Descrição

ASPIRIN at randomisation

Tipo de dados

boolean

If no, indicate reason:
Descrição

no ASPIRIN at randomisation reason

Tipo de dados

text

If other reason, specify:
Descrição

no ASPIRIN at randomisation other reason

Tipo de dados

text

5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
Descrição

P2Y12 inhibitors

Tipo de dados

boolean

If no, indicate reason:
Descrição

no P2Y12 inhibitors reason

Tipo de dados

text

If other reason, specify:
Descrição

no P2Y12 inhibitors other reason

Tipo de dados

text

6. Is the subject taking a beta-blocker?
Descrição

beta-blocker

Tipo de dados

boolean

If no, indicate reason:
Descrição

no beta-blocker reason

Tipo de dados

text

If other reason, specify:
Descrição

no beta-blocker other reason

Tipo de dados

text

7. Is the subject taking an ACE inhibitor?
Descrição

ACE inhibitor

Tipo de dados

boolean

If no, indicate reason:
Descrição

no ACE inhibitor reason

Tipo de dados

text

If other reason, specify:
Descrição

no ACE inhibitors other reason

Tipo de dados

text

8. Is the subject taking an ARB?
Descrição

ARB

Tipo de dados

boolean

If no, indicate reason:
Descrição

no ARB reason

Tipo de dados

text

If other reason, specify:
Descrição

no ARB other reason

Tipo de dados

text

9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
Descrição

renin-angiotensin-aldosterone system-targeted medication

Tipo de dados

boolean

If no, indicate reason:
Descrição

no renin-angiotensin-aldosterone system-targeted medication reason

Tipo de dados

text

If other reason, specify:
Descrição

no renin-angiotensin-aldosterone system-targeted medication other reason

Tipo de dados

text

Voltar ao início da página

Similar models

Standard of care medications GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulários
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Standard of care medications
STATIN therapy prior to randomisation
Item
1. Was the subject regularly taking STATIN therapy for 8 weeks or more prior to randomisation?
boolean
STATIN therapy at randomisation
Item
2. Was the subject taking STATIN therapy at the time of randomisation?
boolean
Item
If no, indicate reason
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
Item
If other reason, specify:
text
no STATIN therapy at randomisation reason
Code List
If other reason, specify:
ASPIRIN therapy prior to randomisation
Item
3. Was the subject regularly taking ASPIRIN therapy for 8 weeks or more prior to randomisation?
boolean
ASPIRIN at randomisation
Item
4. Was the subject taking ASPIRIN at the time of randomisation?
boolean
Item
If no, indicate reason:
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
no ASPIRIN at randomisation other reason
Item
If other reason, specify:
text
P2Y12 inhibitors
Item
5. Is the subject regularly taking any P2Y12 inhibitors (i.e. thienopyridines)?
boolean
Item
If no, indicate reason:
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no P2Y12 inhibitors other reason
Item
If other reason, specify:
text
beta-blocker
Item
6. Is the subject taking a beta-blocker?
boolean
Item
If no, indicate reason:
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no beta-blocker other reason
Item
If other reason, specify:
text
ACE inhibitor
Item
7. Is the subject taking an ACE inhibitor?
boolean
Item
If no, indicate reason:
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ACE inhibitors other reason
Item
If other reason, specify:
text
ARB
Item
8. Is the subject taking an ARB?
boolean
Item
If no, indicate reason:
text
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no ARB other reason
Item
If other reason, specify:
text
renin-angiotensin-aldosterone system-targeted medication
Item
9. Is the subject taking any other renin-angiotensin-aldosterone system-targeted medication?
boolean
no STATIN therapy at randomisation reason
Code List
If no, indicate reason:
CL Item
Subject is intolerant or clinically contraindicated (1)
CL Item
Other (OT)
CL Item
Not clinically indicated (2)
no renin-angiotensin-aldosterone system-targeted medication other reason
Item
If other reason, specify:
text
Voltar ao início da página 

Contacto

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Ajuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial